EE219 Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.520
https://www.valueinhealthjournal.com/article/S1098-3015(23)00620-4/fulltext
Title :
EE219 Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00620-4&doi=10.1016/j.jval.2023.03.520
First page :
Section Title :
Open access? :
No
Section Order :
11898